Search Within

BIPOLAR DEPRESSION
Results 1 - 22 of 22
Pharmacotherapy for Bipolar Depression: A Review of the Evidence

Journal: Current Psychiatry Reviews
Volume: 4,Issue: 3
Page: 145-156
Authors: Trond F. Aarre and Alv A. Dahl

Bipolar Depression: The Neglected Realm of Postpartum Disorders

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 3
Page: 325-329
Authors: Verinder Sharma

Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 8
Page: 858-869
Authors: Gustavo H. Vazquez, Sebastian Camino, Leonardo Tondo and Ross J. Baldessarini*

Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?

Journal: Current Psychopharmacology
Volume: 4,Issue: 2
Page: 84-95
Authors: María Yoldi-Negrete, Claudia Becerra-Palars, Armando Carvajal-Lohr, Alejandra Monserrat Rodríguez-Ramírez and María Alejandra Martín-Manzo

Pramipexole Tachyphylaxis and its Management in Bipolar Depression

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 1
Page: 77-77
Authors: Verinder Sharma

Scopolamine and Depression: A Role for Muscarinic Antagonism?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 4
Page: 673-683
Authors: Helge Hasselmann

N-Acetylcysteine for the Treatment of Obsessive-Compulsive Disorder

Journal: Current Psychiatry Reviews
Volume: 10,Issue: 4
Page: 308-316
Authors: Fabiele M. Fritzen and Michael H. Bloch

Lamotrigine as an Effective Treatment for Behavioral Disorders

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 6
Page: 446-452
Authors: Rita Moretti, Paola Torre, Cristina Vilotti and Rodolfo M. Antonello

The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders:A Potential Noveltreatment?

Journal: Current Neuropharmacology
Volume: 13,Issue: 6
Page: 739-749
Authors: Won Je Jeon, Brian Dean, Elizabeth Scarr and Andrew Gibbons

The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features

Journal: Current Neuropharmacology
Volume: 15,Issue: 3
Page: 359-371
Authors: Giulio Perugi, Pierpaolo Medda, Cristina Toni, Michela Giorgi Mariani, Chiara Socci and Mauro Mauri

BDNF/NF-?B Signaling in the Neurobiology of Depression

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 3154-3163
Authors: Ariel Caviedes, Carlos Lafourcade, Claudio Soto and Ursula Wyneken*

SSRIs, Suicide and Violent Behavior: Is there a Need for a Better Definition of the Depressive State?

Journal: Current Drug Safety
Volume: 1,Issue: 1
Page: 59-62
Authors: Chantal Henry and Jacques Demotes-Mainard

Omega-3 Fatty Acids Supplementation in Psychiatric Disorders: A Systematic Review

Journal: Current Psychopharmacology
Volume: 1,Issue: 4
Page: 353-364
Authors: Silvio Bellino, Paola Bozzatello, Elena Brignolo, Chiara Brunetti and Filippo Bogetto

CB1 Cannabinoid Receptors and their Associated Proteins

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1382-1393
Authors: Allyn C. Howlett, Lawrence C. Blume and George D. Dalton

Antipsychotic Medications in the Treatment of Bipolar Disorder

Journal: Current Drug Targets
Volume: 7,Issue: 9
Page: 1217-1224
Authors: Anton A. Subuh Surja, Rebecca L Tamas and Rif S. El-Mallakh


Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Journal: Current Neuropharmacology
Volume: 13,Issue: 5
Page: 663-680
Authors: Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 5144-5162
Authors: Domenico De Berardis, Laura Orsolini, Felice Iasevoli, Emiliano Prinzivalli, Andrea de Bartolomeis, Nicola Serroni, Monica Mazza, Alessandro Valchera, Michele Fornaro, Roberta Vecchiotti, Alessandro Carano, Gianna Sepede, Federica Vellante, Ilaria Matarazzo, Maurizio Pompili, Giampaolo Perna, Chiara Conti, Cristina Segura-García, Giovanni Martinotti and Massimo Di Giannantonio

Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer s Disease Therapy: Advances in Chemical and Biological Research

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 0
Page: 1-23
Authors: Agnieszka Jankowska, Anna Wesolowska *, Maciej Pawlowski and Grazyna Chlon-Rzepa *

Quetiapine Induced Hypomania: A Case Report and a Review of the Literature

Journal: Current Drug Safety
Volume: 7,Issue: 3
Page: 250-253
Authors: R. Bou Khalil and C. Baddoura

Depression and Mania in Bipolar Disorder

Journal: Current Neuropharmacology
Volume: 15,Issue: 3
Page: 353-358
Authors: Leonardo Tondo, Gustavo H. Vazquez and Ross J. Baldessarini

Commentary [The Mood in the Field of Antidepressant Drug Discovery]

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 7
Page: 762-763
Authors: Jeffrey M. Witkin

Results 1 - 22 of 22